ChabiotechLtd Balance Sheet Health
Financial Health criteria checks 3/6
ChabiotechLtd has a total shareholder equity of ₩792.8B and total debt of ₩744.8B, which brings its debt-to-equity ratio to 93.9%. Its total assets and total liabilities are ₩2,329.2B and ₩1,536.4B respectively.
Key information
93.94%
Debt to equity ratio
₩744.76b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩337.53b |
| Equity | ₩792.81b |
| Total liabilities | ₩1.54t |
| Total assets | ₩2.33t |
Recent financial health updates
ChabiotechLtd (KOSDAQ:085660) Is Carrying A Fair Bit Of Debt
Oct 28
Is ChabiotechLtd (KOSDAQ:085660) A Risky Investment?
Apr 10Is ChabiotechLtd (KOSDAQ:085660) Using Too Much Debt?
Nov 12Is CHA Biotech (KOSDAQ:085660) Using Too Much Debt?
Mar 01Recent updates
Chabiotech Co.,Ltd.'s (KOSDAQ:085660) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Dec 09ChabiotechLtd (KOSDAQ:085660) Is Carrying A Fair Bit Of Debt
Oct 28A Piece Of The Puzzle Missing From Chabiotech Co.,Ltd.'s (KOSDAQ:085660) Share Price
Sep 08Is ChabiotechLtd (KOSDAQ:085660) A Risky Investment?
Apr 10Chabiotech Co.,Ltd. (KOSDAQ:085660) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
Dec 25Is ChabiotechLtd (KOSDAQ:085660) Using Too Much Debt?
Nov 12Chabiotech Co.,Ltd.'s (KOSDAQ:085660) Shares Lagging The Industry But So Is The Business
Aug 07Is CHA Biotech (KOSDAQ:085660) Using Too Much Debt?
Mar 01If You Had Bought CHA Biotech's (KOSDAQ:085660) Shares Three Years Ago You Would Be Down 52%
Jan 25The Trends At CHA Biotech (KOSDAQ:085660) That You Should Know About
Dec 21Financial Position Analysis
Short Term Liabilities: A085660's short term assets (₩787.0B) do not cover its short term liabilities (₩1,159.9B).
Long Term Liabilities: A085660's short term assets (₩787.0B) exceed its long term liabilities (₩376.5B).
Debt to Equity History and Analysis
Debt Level: A085660's net debt to equity ratio (51.4%) is considered high.
Reducing Debt: A085660's debt to equity ratio has increased from 39.1% to 93.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A085660 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: A085660 has sufficient cash runway for 1.4 years if free cash flow continues to reduce at historical rates of 12.2% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/14 08:50 |
| End of Day Share Price | 2026/01/14 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Chabiotech Co.,Ltd. is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sang-Hun Lee | iM Securities |
| Jung-In Lee | Korea Investment & Securities Co., Ltd. |
| Hyung Soo Kim | Kyobo Securities Co., Ltd |